BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9399049)

  • 1. The kidney and von Hippel-Lindau disease: impact of molecular genetic analysis of the VHL gene for clinical management.
    Neumann HP; Bender BU; Schultze-Seemann W; Krause T; Altehoefer C; Scheremet R; Orszagh M; Schwarzkopf G; Januszewicz A; Janetschek G; Riegler P
    Contrib Nephrol; 1997; 122():102-8. PubMed ID: 9399049
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.
    Gorospe M; Egan JM; Zbar B; Lerman M; Geil L; Kuzmin I; Holbrook NJ
    Mol Cell Biol; 1999 Feb; 19(2):1289-300. PubMed ID: 9891063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
    Meister M; Choyke P; Anderson C; Patel U
    Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.
    Ferragut J; Caimari M; Rituerto B; Gómez-Rivas B; Herrera M; Alonso F
    J Pediatr Endocrinol Metab; 1999; 12(4):579-82. PubMed ID: 10417977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).
    Hes FJ; Feldberg MA
    Eur Radiol; 1999; 9(4):598-610. PubMed ID: 10354869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
    Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
    Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
    Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
    J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
    Richard S
    Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
    Petrella BL; Lohi J; Brinckerhoff CE
    Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
    Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
    Humphrey JS; Klausner RD; Linehan WM
    Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
    [No Abstract]   [Full Text] [Related]  

  • 15. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
    Wiesener MS; Eckardt KU
    Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075
    [No Abstract]   [Full Text] [Related]  

  • 17. von Hippel-Lindau disease: genetic and clinical observations.
    Iliopoulos O
    Front Horm Res; 2001; 28():131-66. PubMed ID: 11443850
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
    Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
    Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
    [No Abstract]   [Full Text] [Related]  

  • 19. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
    Decker HJ; Weidt EJ; Brieger J
    Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.